XML 116 R10.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurement
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurement Fair value measurement
Refer to Note 2 of JPMorgan Chase’s 2019 Form 10-K for a discussion of the Firm’s valuation methodologies for assets, liabilities and lending-related commitments measured at fair value and the fair value hierarchy.

The following table presents the assets and liabilities reported at fair value as of March 31, 2020, and December 31, 2019, by major product category and fair value hierarchy.
Assets and liabilities measured at fair value on a recurring basis







Fair value hierarchy

Derivative
netting
adjustments
(f)

 
 
 
 
 
 
 
March 31, 2020 (in millions)
Level 1
Level 2

Level 3

Total fair value

Federal funds sold and securities purchased under resale agreements
$

$
235,859


$


$

$
235,859

Securities borrowed

51,576





51,576

Trading assets:












Debt instruments:












Mortgage-backed securities:












U.S. GSEs and government agencies(a)

87,669


519



88,188

Residential – nonagency

2,665


24



2,689

Commercial – nonagency

2,250


3



2,253

Total mortgage-backed securities

92,584


546



93,130

U.S. Treasury, GSEs and government agencies(a)
91,922

12,722





104,644

Obligations of U.S. states and municipalities

6,489


9



6,498

Certificates of deposit, bankers’ acceptances and commercial paper

3,769

 

 

3,769

Non-U.S. government debt securities
37,860

47,058

 
175

 

85,093

Corporate debt securities

22,192

 
953

 

23,145

Loans(b)

42,754

 
3,354

 

46,108

Asset-backed securities

2,739

 
52

 

2,791

Total debt instruments
129,782

230,307

 
5,089

 

365,178

Equity securities
82,500

97

 
213

 

82,810

Physical commodities(c)
4,684

2,498

 

 

7,182

Other

11,494

 
221

 

11,715

Total debt and equity instruments(d)
216,966

244,396

 
5,523

 

466,885

Derivative receivables:
 
 
 
 
 
 
 
Interest rate
7,333

392,863

 
2,307

 
(365,602
)
36,901

Credit

19,252

 
828

 
(18,895
)
1,185

Foreign exchange
288

242,180

 
1,054

 
(224,539
)
18,983

Equity

91,010

 
5,135

 
(82,930
)
13,215

Commodity

37,309

 
346

 
(26,291
)
11,364

Total derivative receivables
7,621

782,614

 
9,670

 
(718,257
)
81,648

Total trading assets(e)
224,587

1,027,010

 
15,193

 
(718,257
)
548,533

Available-for-sale securities:
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
U.S. GSEs and government agencies(a)

135,620

 

 

135,620

Residential – nonagency

15,443

 

 

15,443

Commercial – nonagency

6,313

 

 

6,313

Total mortgage-backed securities

157,376

 

 

157,376

U.S. Treasury and government agencies
150,235


 

 

150,235

Obligations of U.S. states and municipalities

30,545

 

 

30,545

Certificates of deposit

76

 

 

76

Non-U.S. government debt securities
13,192

9,569

 

 

22,761

Corporate debt securities

802

 

 

802

Asset-backed securities:
 
 
 
 
 
 
 
Collateralized loan obligations

30,975

 

 

30,975

Other

7,174

 

 

7,174

Total available-for-sale securities
163,427

236,517

 

 

399,944

Loans

5,931

 
283

 

6,214

Mortgage servicing rights


 
3,267

 

3,267

Other assets(e)
6,923

12,724

 
416

 

20,063

Total assets measured at fair value on a recurring basis
$
394,937

$
1,569,617

 
$
19,159

 
$
(718,257
)
$
1,265,456

Deposits
$

$
19,430

 
$
3,179

 
$

$
22,609

Federal funds purchased and securities loaned or sold under repurchase agreements

194,690

 

 

194,690

Short-term borrowings

22,281

 
2,039

 

24,320

Trading liabilities:
 
 
 
 
 
 


Debt and equity instruments(d)
95,909

23,139

 
61

 

119,109

Derivative payables:
 
 
 
 
 
 


Interest rate
8,752

353,858

 
2,443

 
(351,654
)
13,399

Credit

19,939

 
939

 
(18,766
)
2,112

Foreign exchange
283

253,779

 
1,981

 
(232,749
)
23,294

Equity

88,241

 
5,961

 
(82,165
)
12,037

Commodity

39,229

 
771

 
(25,755
)
14,245

Total derivative payables
9,035

755,046

 
12,095

 
(711,089
)
65,087

Total trading liabilities
104,944

778,185

 
12,156

 
(711,089
)
184,196

Accounts payable and other liabilities
3,407

709

 
15

 

4,131

Beneficial interests issued by consolidated VIEs

77

 

 

77

Long-term debt

48,476

 
20,141

 

68,617

Total liabilities measured at fair value on a recurring basis
$
108,351

$
1,063,848

 
$
37,530

 
$
(711,089
)
$
498,640



Fair value hierarchy

Derivative
netting
adjustments
(f)
 

 
 
 
 
 
 
 
 
December 31, 2019 (in millions)
Level 1
Level 2

Level 3

 
Total fair value

Federal funds sold and securities purchased under resale agreements
$

$
14,561


$


$

 
$
14,561

Securities borrowed

6,237





 
6,237

Trading assets:
 
 

 

 
 
 
Debt instruments:
 
 

 

 
 
 
Mortgage-backed securities:
 
 

 

 
 
 
U.S. GSEs and government agencies(a)

44,510


797



 
45,307

Residential – nonagency

1,977


23



 
2,000

Commercial – nonagency

1,486


4



 
1,490

Total mortgage-backed securities

47,973


824



 
48,797

U.S. Treasury, GSEs and government agencies(a)
78,289

10,295





 
88,584

Obligations of U.S. states and municipalities

6,468


10



 
6,478

Certificates of deposit, bankers’ acceptances and commercial paper

252





 
252

Non-U.S. government debt securities
26,600

27,169


155



 
53,924

Corporate debt securities

17,956


558



 
18,514

Loans(b)

47,047


1,382



 
48,429

Asset-backed securities

2,593


37



 
2,630

Total debt instruments
104,889

159,753


2,966



 
267,608

Equity securities
71,890

244


196



 
72,330

Physical commodities(c)
3,638

3,579





 
7,217

Other

13,896


232



 
14,128

Total debt and equity instruments(d)
180,417

177,472


3,394



 
361,283

Derivative receivables:
 








 


Interest rate
721

311,173


1,400


(285,873
)
 
27,421

Credit

14,252


624


(14,175
)
 
701

Foreign exchange
117

137,938


432


(129,482
)
 
9,005

Equity

43,642


2,085


(39,250
)
 
6,477

Commodity

17,058


184


(11,080
)
 
6,162

Total derivative receivables
838

524,063


4,725


(479,860
)
 
49,766

Total trading assets(e)
181,255

701,535


8,119


(479,860
)
 
411,049

Available-for-sale securities:
 








 


Mortgage-backed securities:
 








 


U.S. GSEs and government agencies(a)

110,117





 
110,117

Residential – nonagency

12,989


1



 
12,990

Commercial – nonagency

5,188





 
5,188

Total mortgage-backed securities

128,294


1



 
128,295

U.S. Treasury and government agencies
139,436






 
139,436

Obligations of U.S. states and municipalities

29,810





 
29,810

Certificates of deposit

77





 
77

Non-U.S. government debt securities
12,966

8,821





 
21,787

Corporate debt securities

845





 
845

Asset-backed securities:
 








 


Collateralized loan obligations

24,991





 
24,991

Other

5,458





 
5,458

Total available-for-sale securities
152,402

198,296


1



 
350,699

Loans

7,104





 
7,104

Mortgage servicing rights



4,699



 
4,699

Other assets(e)
7,305

452


724



 
8,481

Total assets measured at fair value on a recurring basis
$
340,962

$
928,185


$
13,543


$
(479,860
)
 
$
802,830

Deposits
$

$
25,229


$
3,360


$

 
$
28,589

Federal funds purchased and securities loaned or sold under repurchase agreements

549





 
549

Short-term borrowings

4,246


1,674



 
5,920

Trading liabilities:
 
 

 



 


Debt and equity instruments(d)
59,047

16,481


41



 
75,569

Derivative payables:
 
 




 
 
 
Interest rate
795

276,746


1,732


(270,670
)
 
8,603

Credit

14,358


763


(13,469
)
 
1,652

Foreign exchange
109

143,960


1,039


(131,950
)
 
13,158

Equity

47,261


5,480


(40,204
)
 
12,537

Commodity

19,685


200


(12,127
)
 
7,758

Total derivative payables
904

502,010


9,214


(468,420
)
 
43,708

Total trading liabilities
59,951

518,491


9,255


(468,420
)
 
119,277

Accounts payable and other liabilities
3,231

452


45



 
3,728

Beneficial interests issued by consolidated VIEs

36





 
36

Long-term debt

52,406


23,339



 
75,745

Total liabilities measured at fair value on a recurring basis
$
63,182

$
601,409


$
37,673


$
(468,420
)
 
$
233,844

(a)
At March 31, 2020, and December 31, 2019, included total U.S. GSE obligations of $161.2 billion and $104.5 billion, respectively, which were mortgage-related.
(b)
At March 31, 2020, and December 31, 2019, included within trading loans were $15.9 billion and $19.8 billion, respectively, of residential first-lien mortgages, and $3.0 billion and $3.4 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. GSEs and government agencies of $8.9 billion and $13.6 billion, respectively.
(c)
Physical commodities inventories are generally accounted for at the lower of cost or net realizable value. “Net realizable value” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, net realizable value approximates fair value for the Firm’s physical commodities
inventories. When fair value hedging has been applied (or when net realizable value is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. Refer to Note 5 for a further discussion of the Firm’s hedge accounting relationships. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented.
(d)
Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions).
(e)
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not required to be classified in the fair value hierarchy. At March 31, 2020, and December 31, 2019, the fair values of these investments, which include certain hedge funds, private equity funds, real estate and other funds, were $659 million and $684 million, respectively. Included in these balances at March 31, 2020, and December 31, 2019, were trading assets of $47 million and $54 million, respectively, and other assets of $612 million and $630 million, respectively.
(f)
As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. The level 3 balances would be reduced if netting were applied, including the netting benefit associated with cash collateral.
Level 3 valuations
Refer to Note 2 of JPMorgan Chase’s 2019 Form 10-K for further information on the Firm’s valuation process and a detailed discussion of the determination of fair value for individual financial instruments.
The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and the weighted or arithmetic averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy.
The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value.
In the Firm’s view, the input range, weighted and arithmetic average values do not reflect the degree of input uncertainty or an assessment of the reasonableness of the Firm’s estimates and assumptions. Rather, they reflect the characteristics of the various instruments held by the Firm and the relative distribution of instruments within the range of characteristics. For example, two option contracts may have similar levels of market risk exposure and valuation uncertainty, but may have significantly different implied volatility levels because the option contracts have different underlyings, tenors, or strike prices. The input range and weighted average values will therefore vary from period-to-period and parameter-to-parameter based on the characteristics of the instruments held by the Firm at each balance sheet date.


Level 3 inputs(a)
 
 
 
 
 
 
March 31, 2020
 
 
 
 
 
 
Product/Instrument
Fair value
(in millions)
 
Principal valuation technique
Unobservable inputs(g)
Range of input values
Average(i)
Residential mortgage-backed securities and loans(b)
$
1,142

 
Discounted cash flows
Yield
1%
25%
 
5%
 
 
 
Prepayment speed
0%
39%
 
11%
 
 
 
 
Conditional default rate
0%
30%
 
14%
 
 
 
 
Loss severity
0%
100%
 
8%
Commercial mortgage-backed securities and loans(c)
509

 
Market comparables
Price
$0
$106
 
$92
Obligations of U.S. states and municipalities
9

 
Market comparables
Price
$78
$100
 
$97
Corporate debt securities
953

 
Market comparables
Price
$4
$104
 
$71
Loans(d)
167

 
Discounted cash flows
Yield
4%
30%
 
7%
 
2,365

 
Market comparables
Price
$5
$100
 
$73
Asset-backed securities
52

 
Market comparables
Price
$1
$94
 
$61
Net interest rate derivatives
(192
)
 
Option pricing
Interest rate volatility
6%
91%
 
21%
 
 
 
 
Interest rate spread volatility
16 bps
30 bps
 
23 bps
 
 
 
 
Interest rate correlation
(65)%
94%
 
38%
 
 
 
 
IR-FX correlation
(50)%
35%
 
1%
 
56

 
Discounted cash flows
Prepayment speed
4%
30%
 
3%
Net credit derivatives
(147
)
 
Discounted cash flows
Credit correlation
37%
77%
 
50%
 
 
 
 
Credit spread
8 bps
2,230 bps
 
516 bps
 
 
 
 
Recovery rate
1%
70%
 
50%
 
 
 
 
Conditional default rate
2%
23%
 
11%
 
 
 
 
Loss severity
100%
 
100%
 
36

 
Market comparables
Price
$1
$115
 
$60
Net foreign exchange derivatives
(784
)
 
Option pricing
IR-FX correlation
(58)%
70%
 
33%
 
(143
)
 
Discounted cash flows
Prepayment speed
9%
 
9%
Net equity derivatives
(826
)
 
Option pricing
Forward equity price(h)
54%
106%
 
98%
 
 
 
 
Equity volatility
4%
179%
 
40%
 
 
 
 
Equity correlation
25%
100%
 
78%
 
 
 
 
Equity-FX correlation
(77)%
40%
 
(17)%
 
 
 
 
Equity-IR correlation
20%
35%
 
28%
Net commodity derivatives
(425
)
 
Option pricing
Forward industrial metal price
$ 1,166 / MT
$ 15,357 / MT
 
$ 6,159 / MT
 
 
 
 
Forward power price
$ 12 /MWH
$ 53 /MWH
 
$ 22 /MWH
 
 
 
 
Commodity volatility
3%
236%
 
29%
 
 
 
 
Commodity correlation
(45)%
95%
 
31%
MSRs
3,267

 
Discounted cash flows
Refer to Note 15
 
 
Other assets
242

 
Discounted cash flows
Credit spread
45 bps
 
45 bps
 
 
 
 
Yield
12%
 
12%
 
395

 
Market comparables
Price
$16
$119
 
$37
Long-term debt, short-term borrowings, and deposits(e)
25,359

 
Option pricing
Interest rate volatility
6%
91%
 
21%
 
 
 
Interest rate correlation
(65)%
94%
 
38%
 
 
 
IR-FX correlation
(50)%
35%
 
1%
 
 
 
Equity correlation
25%
100%
 
78%
 
 
 
Equity-FX correlation
(77)%
40%
 
(17)%
 
 
 
Equity-IR correlation
20%
35%
 
28%
Other level 3 assets and liabilities, net(f)
312

 
 
 
 
 
 
 
 
(a)
The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets. Furthermore, the inputs presented for each valuation technique in the table are, in some cases, not applicable to every instrument valued using the technique as the characteristics of the instruments can differ.
(b)
Comprises U.S. GSEs and government agency securities of $519 million, nonagency securities of $24 million and trading loans of $599 million.
(c)
Comprises nonagency securities of $3 million, trading loans of $223 million and non-trading loans of $283 million.
(d)
Comprises trading loans.
(e)
Long-term debt, short-term borrowings and deposits include structured notes issued by the Firm that are financial instruments that typically contain embedded derivatives. The estimation of the fair value of structured notes includes the derivative features embedded within the instrument. The significant unobservable inputs are broadly consistent with those presented for derivative receivables.
(f)
Includes level 3 assets and liabilities that are insignificant both individually and in aggregate.
(g)
Price is a significant unobservable input for certain instruments. When quoted market prices are not readily available, reliance is generally placed on price-based internal valuation techniques. The price input is expressed assuming a par value of $100.
(h)
Forward equity price is expressed as a percentage of the current equity price.
(i)
Amounts represent weighted averages except for derivative related inputs where arithmetic averages are used.
Changes in and ranges of unobservable inputs
Refer to Note 2 of JPMorgan Chase’s 2019 Form 10-K for a discussion of the impact on fair value of changes in unobservable inputs and the relationships between unobservable inputs as well as a description of attributes of the underlying instruments and external market factors that affect the range of inputs used in the valuation of the Firm’s positions.
Changes in level 3 recurring fair value measurements
The following tables include a rollforward of the Consolidated balance sheets amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the three months ended March 31, 2020 and 2019. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable inputs to the overall fair value measurement. However, level 3 financial instruments
typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. Also, the Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments.


 
Fair value measurements using significant unobservable inputs
 
 
Three months ended
March 31, 2020
(in millions)
Fair value at
Jan 1,
2020
Total realized/unrealized gains/(losses)
 
 
 
 
Transfers into
level 3
(h)
Transfers (out of) level 3(h)
Fair value at
March 31, 2020
Change in unrealized gains/(losses) related
to financial instruments held at March 31, 2020
Purchases(f)
Sales
 
Settlements(g)
Assets:(a)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. GSEs and government agencies
$
797

 
$
(139
)
 
$
19

$
(116
)
 
$
(42
)
$

$

 
$
519

 
$
(131
)
 
Residential – nonagency
23

 
(1
)
 
2


 



 
24

 
(1
)
 
Commercial – nonagency
4

 

 
1


 
(1
)
1

(2
)
 
3

 

 
Total mortgage-backed securities
824

 
(140
)
 
22

(116
)
 
(43
)
1

(2
)
 
546

 
(132
)
 
Obligations of U.S. states and municipalities
10

 

 

(1
)
 



 
9

 

 
Non-U.S. government debt securities
155

 
(12
)
 
90

(57
)
 


(1
)
 
175

 
(10
)
 
Corporate debt securities
558

 
(55
)
 
292

(42
)
 

227

(27
)
 
953

 
(50
)
 
Loans
1,382

 
(161
)
 
699

(162
)
 
(53
)
1,788

(139
)
 
3,354

 
(190
)
 
Asset-backed securities
37

 
(2
)
 
36

(15
)
 
(1
)

(3
)
 
52

 
(1
)
 
Total debt instruments
2,966

 
(370
)
 
1,139

(393
)
 
(97
)
2,016

(172
)
 
5,089

 
(383
)
 
Equity securities
196

 
(38
)
 
10

(4
)
 

82

(33
)
 
213

 
(39
)
 
Other
232

 
(1
)
 
9

(5
)
 
(12
)

(2
)
 
221

 
2

 
Total trading assets – debt and equity instruments
3,394

 
(409
)
(c) 
1,158

(402
)
 
(109
)
2,098

(207
)
 
5,523

 
(420
)
(c) 
Net derivative receivables:(b)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate
(332
)
 
642

 
66

(50
)
 
(241
)
(172
)
(49
)
 
(136
)
 
282

 
Credit
(139
)
 
108

 
18

(128
)
 
(33
)
60

3

 
(111
)
 
65

 
Foreign exchange
(607
)
 
(339
)
 
38

(4
)
 
(14
)

(1
)
 
(927
)
 
(508
)
 
Equity
(3,395
)
 
3,037

 
59

(548
)
 
583

(656
)
94

 
(826
)
 
3,707

 
Commodity
(16
)
 
(403
)
 
4

(15
)
 
9

(6
)
2

 
(425
)
 
(399
)
 
Total net derivative receivables
(4,489
)
 
3,045

(c) 
185

(745
)
 
304

(774
)
49

 
(2,425
)
 
3,147

(c) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities
1

 

 


 
(1
)


 

 

 
Total available-for-sale securities
1

 




 
(1
)


 

 


Loans

 
(11
)
(c) 


 

294


 
283

 
(10
)
(c) 
Mortgage servicing rights
4,699

 
(1,382
)
(d) 
273

(75
)
 
(248
)


 
3,267

 
(1,382
)
(d) 
Other assets
724

 
(82
)
(c) 
2

(28
)
 
(200
)


 
416

 
(81
)
(c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
 
Three months ended
March 31, 2020
(in millions)
Fair value at
Jan 1,
2020
Total realized/unrealized (gains)/losses
 
 
 
 
Transfers into
level 3
(h)
Transfers (out of) level 3(h)
Fair value at
March 31, 2020
Change in unrealized (gains)/losses related
to financial instruments held at March 31, 2020
Purchases
Sales
Issuances
Settlements(g)
Liabilities:(a)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
3,360

 
$
(149
)
(c)(e) 
$

$

$
386

$
(172
)
$
4

$
(250
)
 
$
3,179

 
$
(135
)
(c)(e) 
Short-term borrowings
1,674

 
(345
)
(c)(e) 


1,615

(929
)
40

(16
)
 
2,039

 
(409
)
(c)(e) 
Trading liabilities – debt and equity instruments
41

 
3

(c) 
(75
)
7



86

(1
)
 
61

 
6

(c) 
Accounts payable and other liabilities
45

 
(8
)
(c) 
(23
)
1





 
15

 
(7
)
(c) 
Beneficial interests issued by consolidated VIEs

 








 

 


Long-term debt
23,339

 
(4,110
)
(c)(e) 


4,607

(3,549
)
370

(516
)
 
20,141

 
(3,984
)
(c)(e) 

Fair value measurements using significant unobservable inputs

 
Three months ended
March 31, 2019
(in millions)
Fair value at
Jan 1,
2019
 
Total realized/unrealized gains/(losses)


 

 


Transfers into
level 3
(h)
Transfers (out of) level 3(h)
Fair value at
March 31, 2019
Change in unrealized gains/(losses) related
to financial instruments held at March 31, 2019
Purchases(f)
Sales
 

 
Settlements(g)
 
Assets:(a)

 




 

 



 









Trading assets:

 




 

 



 









Debt instruments:

 




 

 



 









Mortgage-backed securities:

 




 

 



 









U.S. GSEs and government agencies
$
549

 
$
(15
)

$
5

$
(100
)
 

 
$
(18
)

$
1

$
(10
)

$
412


$
(16
)

Residential – nonagency
64

 
24


70

(69
)
 

 
(1
)

15

(18
)

85


1


Commercial – nonagency
11

 
2


12

(19
)
 

 
(2
)

15

(2
)

17


1


Total mortgage-backed securities
624

 
11


87

(188
)
 

 
(21
)

31

(30
)

514


(14
)

Obligations of U.S. states and municipalities
689

 
13


1

(74
)
 

 
(6
)




623


14


Non-U.S. government debt securities
155

 
(1
)

71

(54
)
 

 


2

(3
)

170


(1
)

Corporate debt securities
334

 
22


223

(7
)
 

 


28

(32
)

568


39


Loans
1,706

 
83


72

(118
)
 

 
(120
)

159

(41
)

1,741


83


Asset-backed securities
127

 
(2
)

17

(21
)
 

 
(7
)

20

(15
)

119


(4
)

Total debt instruments
3,635

 
126


471

(462
)
 

 
(154
)

240

(121
)

3,735


117


Equity securities
232

 
(2
)

15

(79
)
 

 
(22
)

75

(17
)

202


(2
)

Other
301

 
4


12

(1
)
 

 
(11
)

1

(2
)

304


13


Total trading assets – debt and equity instruments
4,168

 
128

(c) 
498

(542
)
 

 
(187
)

316

(140
)

4,241


128

(c) 
Net derivative receivables:(b)


 







 

 



 









Interest rate
(38
)
 
(322
)

19

(27
)
(i) 

 
178

(i) 
18

25


(147
)

(376
)

Credit
(107
)
 
(17
)


(1
)
 

 
6


3

1


(115
)

(21
)

Foreign exchange
(297
)
 
(245
)

1

(9
)
 

 
181


(8
)
21


(356
)

(220
)

Equity
(2,225
)
 
731


127

(297
)
 

 
(401
)

(67
)
66


(2,066
)

226


Commodity
(1,129
)
 
533


3

(88
)
 

 
24


1

(9
)

(665
)

507


Total net derivative receivables
(3,796
)
 
680

(c) 
150

(422
)
 

 
(12
)

(53
)
104


(3,349
)

116

(c) 
Available-for-sale securities:
 
 
 

 
 
 

 
 

 
 

 

 

Mortgage-backed securities
1

 




 

 
(1
)








Total available-for-sale securities
1

 




 

 
(1
)








Loans
122

 
3

(c) 


 

 
(2
)




123


3

(c) 
Mortgage servicing rights
6,130

 
(299
)
(d) 
436

(111
)
 

 
(199
)




5,957


(299
)
(d) 
Other assets
927

 
(7
)
(c) 
9

(80
)
 
 
 
(1
)
 

(7
)
 
841

 
(10
)
(c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Fair value measurements using significant unobservable inputs


Three months ended
March 31, 2019
(in millions)
Fair value at
Jan 1,
2019
 
Total realized/unrealized (gains)/losses


 

 

 
Transfers into
level 3
(h)
Transfers (out of) level 3(h)
Fair value at
March 31, 2019
Change in unrealized (gains)/losses related
to financial instruments held at March 31, 2019
Purchases
Sales
 
Issuances
Settlements(g)

Liabilities:(a)

 




 

 


 
 








Deposits
$
4,169

 
$
152

(c)(e) 
$

$

 
$
335

 
$
(24
)

$

$
(104
)

$
4,528


$
144

(c)(e) 
Short-term borrowings
1,523

 
46

(c)(e) 


 
651

 
(601
)

1

(118
)

1,502


80

(c)(e) 
Trading liabilities – debt and equity instruments
50

 


(2
)
11

 

 


3

(10
)

52


1

(c) 
Accounts payable and other liabilities
10

 


(5
)
10

 

 





15




Beneficial interests issued by consolidated VIEs
1

 
(1
)
(c) 


 

 









Long-term debt
19,418

 
1,273

(c)(e) 


 
2,051

 
(1,188
)

273

(172
)

21,655


1,625

(c)(e) 

(a)
Level 3 assets as a percentage of total Firm assets accounted for at fair value (including assets measured at fair value on a nonrecurring basis) were 2% at both March 31, 2020 and December 31, 2019, respectively. Level 3 liabilities as a percentage of total Firm liabilities accounted for at fair value (including liabilities measured at fair value on a nonrecurring basis) were 8% and 16%, at March 31, 2020 and December 31, 2019, respectively.
(b)
All level 3 derivatives are presented on a net basis, irrespective of the underlying counterparty.
(c)
Predominantly reported in principal transactions revenue, except for changes in fair value for CCB mortgage loans and lending-related commitments originated with the intent to sell, and mortgage loan purchase commitments, which are reported in mortgage fees and related income.
(d)
Changes in fair value for MSRs are reported in mortgage fees and related income.
(e)
Realized (gains)/losses due to DVA for fair value option elected liabilities are reported in principal transactions revenue, and were not material for the three months ended March 31, 2020 and 2019, respectively. Unrealized (gains)/losses are reported in OCI, and they were $(1.1) billion and $176 million for the three months ended March 31, 2020 and 2019, respectively.
(f)
Loan originations are included in purchases.
(g)
Includes financial assets and liabilities that have matured, been partially or fully repaid, impacts of modifications, deconsolidations associated with beneficial interests in VIEs and other items.
(h)
All transfers into and/or out of level 3 are based on changes in the observability and/or significance of the valuation inputs and are assumed to occur at the beginning of the quarterly reporting period in which they occur.
(i)
The prior-period amounts have been revised to conform with the current period presentation.
Level 3 analysis
Consolidated balance sheets changes
Level 3 assets, including assets measured at fair value on a nonrecurring basis, were 0.6% of total Firm assets at March 31, 2020. The following describes significant changes to level 3 assets since December 31, 2019, for those items measured at fair value on a recurring basis. Refer to Assets and liabilities measured at fair value on a nonrecurring basis on page 96 for further information on changes impacting items measured at fair value on a nonrecurring basis.
Three months ended March 31, 2020
Level 3 assets were $19.2 billion at March 31, 2020, reflecting an increase of $5.6 billion from December 31, 2019 reflective of heightened market volatility and net transfers largely due to:
$2.0 billion increase in trading loans.
$3.1 billion increase in gross equity derivative receivables.
$1.4 billion decrease in MSRs.
Refer to the sections below for additional information.
Transfers between levels for instruments carried at fair value on a recurring basis
For the three months ended March 31, 2020, significant transfers from level 2 into level 3 included the following:
$2.1 billion of total debt and equity instruments, predominantly trading loans, driven by a decrease in observability.
$1.0 billion of gross equity derivative receivables and $1.7 billion of gross equity derivative payables as a result of a decrease in observability and an increase in the significance of unobservable inputs.
For the three months ended March 31, 2020, there were no significant transfers from level 3 into level 2.
For the three months ended March 31, 2019, there were no significant transfers from level 2 into level 3 or from level 3 into level 2.
All transfers are based on changes in the observability and/or significance of the valuation inputs and are assumed to occur at the beginning of the quarterly reporting period in which they occur.
Gains and losses
The following describes significant components of total realized/unrealized gains/(losses) for instruments measured at fair value on a recurring basis for the periods indicated. These amounts exclude any effects of the Firm’s risk management activities where the financial instruments are classified as level 1 and 2 of the fair value hierarchy. Refer to Changes in level 3 recurring fair value measurements rollforward tables on pages 92–95 for further information on these instruments.
Three months ended March 31, 2020
$1.2 billion of net gains on assets, driven by gains in net equity derivative receivables due to market movements largely offset by losses in MSRs reflecting faster prepayment speeds on lower rates. Refer to Note 15 for information on MSRs.
$4.6 billion of net gains on liabilities, predominantly driven by market movements in long-term debt.
Three months ended March 31, 2019
$505 million of net gains on assets, none of which were individually significant.
$1.5 billion of net losses on liabilities predominantly driven by market movements in long-term debt.
Credit and funding adjustments — derivatives
The following table provides the impact of credit and funding adjustments on principal transactions revenue in the respective periods, excluding the effect of any associated hedging activities. The FVA presented below includes the impact of the Firm’s own credit quality on the inception value of liabilities as well as the impact of changes in the Firm’s own credit quality over time.
 
Three months ended March 31,
(in millions)
2020

 
2019

Credit and funding adjustments:
 
 
 
Derivatives CVA
$
(924
)
 
$
60

Derivatives FVA
(1,021
)
 
152


Refer to Note 2 of JPMorgan Chase’s 2019 Form 10-K for further information about both credit and funding adjustments, as well as information about valuation adjustments on fair value option elected liabilities.
Assets and liabilities measured at fair value on a nonrecurring basis
The following tables present the assets and liabilities held as of March 31, 2020 and 2019, respectively, for which nonrecurring fair value adjustments were recorded during the three months ended March 31, 2020 and 2019, respectively, by major product category and fair value hierarchy.
 
Fair value hierarchy
 
Total fair value
March 31, 2020 (in millions)
Level 1

Level 2

 
Level 3

 
Loans
$

$
2,336

(c) 
$
559

(d) 
$
2,895

Other assets(a)

11

 
334

 
345

Total assets measured at fair value on a nonrecurring basis
$

$
2,347

 
$
893

 
$
3,240

Accounts payable and other liabilities(b)


 
775

  
775

Total liabilities measured at fair value on a nonrecurring basis
$

$

 
$
775

 
$
775

 
Fair value hierarchy
 
Total fair value
March 31, 2019 (in millions)
Level 1

Level 2

 
Level 3

 
Loans
$

$
441

 
$
84

 
$
525

Other assets

11

 
456

 
467

Total assets measured at fair value on a nonrecurring basis
$

$
452

 
$
540

 
$
992

(a)
Primarily includes equity securities without readily determinable fair values that were adjusted based on observable price changes in orderly transactions from an identical or similar investment of the same issuer (measurement alternative). Of the $334 million in level 3 assets measured at fair value on a nonrecurring basis as of March 31, 2020, $194 million related to equity securities adjusted based on the measurement alternative. These equity securities are classified as level 3 due to the infrequency of the observable prices and/or the restrictions on the shares.
(b)
Represents at March 31, 2020 the markdowns associated with $9.4 billion of held-for-sale positions related to unfunded commitments in the bridge financing portfolio. There were no liabilities measured at fair value on a nonrecurring basis at March 31, 2019.
(c)
Primarily includes certain mortgage loans that were reclassified to held-for-sale.
(d)
Of the $559 million in level 3 assets measured at fair value on a nonrecurring basis as of March 31, 2020, $294 million related to residential real estate loans carried at the net realizable value of the underlying collateral (e.g., collateral-dependent loans). These amounts are classified as level 3 as they are valued using information from broker’s price opinions, appraisals and automated valuation models and discounted based upon the Firm’s experience with actual liquidation values. These discounts ranged from 16% to 46% with a weighted average of 28%.
Nonrecurring fair value changes
The following table presents the total change in value of assets and liabilities for which fair value adjustments have been recognized for the three months ended March 31, 2020 and 2019, related to assets and liabilities held at those dates.
 
Three months ended March 31,
(in millions)
2020
 
2019
Loans
$
(267
)
(b) 
$
(21
)
Other assets(a)
(169
)
  
71

Accounts payable and other liabilities
(775
)
(c) 

Total nonrecurring fair value gains/(losses)
$
(1,211
)
 
$
50

(a)
Included $(154) million and $78 million for the three months ended March 31, 2020 and 2019, respectively of net (losses)/gains as a result of the measurement alternative.
(b)
Includes the impact of certain mortgage loans that were reclassified to held-for-sale.
(c)
Represents markdowns on held-for-sale positions related to unfunded commitments in the bridge financing portfolio.
Refer to Note 12 for further information about the measurement of collateral-dependent loans.
Equity securities without readily determinable fair values
The Firm measures certain equity securities without readily determinable fair values at cost less impairment (if any), plus or minus observable price changes from an identical or similar investment of the same issuer, with such changes recognized in other income.
In its determination of the new carrying values upon observable price changes, the Firm may adjust the prices if deemed necessary to arrive at the Firm’s estimated fair values. Such adjustments may include adjustments to reflect the different rights and obligations of similar securities, and other adjustments that are consistent with the Firm’s valuation techniques for private equity direct investments.
The following table presents the carrying value of equity securities without readily determinable fair values still held as of March 31, 2020 and 2019, that are measured under the measurement alternative and the related adjustments recorded during the periods presented for those securities with observable price changes. These securities are included in the nonrecurring fair value tables when applicable price changes are observable.
 
Three months ended
 
March 31
As of or for the period ended,
 
 
 
(in millions)
2020
 
2019
Other assets
 
 
 
Carrying value(a)
$
2,560

 
$
1,819

Upward carrying value changes(b)
9

 
84

Downward carrying value changes/impairment(c)
(162
)
 
(6
)
(a)
The carrying value as of December 31, 2019 was $2.4 billion.
(b)
The cumulative upward carrying value changes between January 1, 2018 and March 31, 2020 were $524 million.
(c)
The cumulative downward carrying value changes/impairment between January 1, 2018 and March 31, 2020 were $(360) million.
Included in other assets above is the Firm’s interest in approximately 40 million Visa Class B shares, recorded at a nominal carrying value. These shares are subject to certain transfer restrictions currently and will be convertible into Visa Class A shares upon final resolution of certain litigation matters involving Visa. The conversion rate of Visa Class B shares into Visa Class A shares is 1.6228 at March 31, 2020, and may be adjusted by Visa depending on developments related to the litigation matters.
Additional disclosures about the fair value of financial instruments that are not carried on the Consolidated balance sheets at fair value
The following table presents by fair value hierarchy classification the carrying values and estimated fair values at March 31, 2020, and December 31, 2019, of financial assets and liabilities, excluding financial instruments that are carried at fair value on a recurring basis, and their classification within the fair value hierarchy.
 
March 31, 2020
 
December 31, 2019
 
 
Estimated fair value hierarchy
 
 
 
Estimated fair value hierarchy
 
(in billions)
Carrying
value
Level 1
Level 2
Level 3
Total estimated
fair value
 
Carrying
value
Level 1
Level 2
Level 3
Total estimated
fair value
Financial assets
 
 
 
 
 
 
 
 
 
 
 
Cash and due from banks
$
24.0

$
24.0

$

$

$
24.0

 
$
21.7

$
21.7

$

$

$
21.7

Deposits with banks
343.5

343.5



343.5

 
241.9

241.9



241.9

Accrued interest and accounts receivable
121.3


121.3


121.3

 
71.3


71.2

0.1

71.3

Federal funds sold and securities purchased under resale agreements
12.7


12.7


12.7

 
234.6


234.6


234.6

Securities borrowed
88.3


88.3


88.3

 
133.5


133.5


133.5

Investment securities, held-to-maturity
71.2

0.1

73.4


73.5

 
47.5

0.1

48.8


48.9

Loans, net of allowance for loan losses(a)
985.9


217.4

778.6

996.0

 
939.5


214.1

734.9

949.0

Other
93.5


92.9

0.8

93.7

 
61.3


60.6

0.8

61.4

Financial liabilities
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
1,813.4

$

$
1,813.7

$

$
1,813.7

 
$
1,533.8

$

$
1,534.1

$

$
1,534.1

Federal funds purchased and securities loaned or sold under repurchase agreements
38.5


38.5


38.5

 
183.1


183.1


183.1

Short-term borrowings
27.6


27.6


27.6

 
35.0


35.0


35.0

Accounts payable and other liabilities
211.3

0.5

206.2

4.2

210.9

 
164.0

0.1

160.0

3.5

163.6

Beneficial interests issued by consolidated VIEs
19.6


19.6


19.6

 
17.8


17.9


17.9

Long-term debt
230.5


219.8

3.5

223.3

 
215.5


218.3

3.5

221.8


(a)
Fair value is typically estimated using a discounted cash flow model that incorporates the characteristics of the underlying loans (including principal, contractual interest rate and contractual fees) and other key inputs, including expected lifetime credit losses, interest rates, prepayment rates, and primary origination or secondary market spreads. For certain loans, the fair value is measured based on the value of the underlying collateral. Carrying value of the loan takes into account the loan’s allowance for loan losses, which represents the loan’s expected credit losses over its remaining expected life. The difference between the estimated fair value and carrying value of a loan is generally attributable to changes in market interest rates, including credit spreads, market liquidity premiums and other factors that affect the fair value of a loan but do not affect its carrying value.
The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated balance sheets. The carrying value and the estimated fair value of these wholesale lending-related commitments were as follows for the periods indicated.
 
March 31, 2020
 
December 31, 2019
 
 
Estimated fair value hierarchy
 
 
 
Estimated fair value hierarchy
 
(in billions)
Carrying value(a) (b)
Level 1
Level 2
Level 3
Total estimated fair value
 
Carrying value(a)
Level 1
Level 2
Level 3
Total estimated fair value
Wholesale lending-related commitments
$
2.8

$

$

$
3.3

$
3.3

 
$
1.2

$

$

$
1.9

$
1.9

(a)
Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which is recognized at fair value at the inception of the guarantees.
(b)
Includes the wholesale allowance for lending-related commitments and markdowns associated with held-for-sale positions related to unfunded commitments in the bridge financing portfolio.
The Firm does not estimate the fair value of consumer off-balance sheet lending-related commitments. In many cases, the Firm can reduce or cancel these commitments by providing the borrower notice or, in some cases as permitted by law, without notice. Refer to page 156 of JPMorgan Chase’s 2019 Form 10-K for a further discussion of the valuation of lending-related commitments.